Tag: FV Pharma

July 2, 2019

FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals

FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA:0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D...
June 24, 2019

FSD Pharma Receives Full “Sale for Medical Purposes” Cannabis License from Health Canada

Full license allows FSD to deliver cannabis to medicinal use markets.
June 12, 2019

FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

FSD Pharma Inc, (CSE:HUGE)(OTCQB:FSDDF) (FRA:0K9) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company's...
June 6, 2019

FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

FSD Pharma Inc, (CSE:HUGE)(OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), is pleased to announce the addition of two distinguished cannabis researchers to the company’s Scientific...
June 3, 2019

FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

FSD Pharma Inc, (CSE:HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), unanimously voted Raza Bokhari, M.D., Executive Co-Chairman of...
May 31, 2019

FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

FSD Pharma Inc, (CSE:HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") would like to congratulate High Tide Inc. (CSE:...
May 28, 2019

Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division

FSD Pharma Inc, (CSE:HUGE)(OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), today announced the appointment of pharmaceutical industry leader, Edward...